Skip to content

Phytoserms for Menopause Symptoms and Age-Associated Memory Decline

Estrogen Receptor-beta phytoSERMs for Management of Menopause and Age-Associated Memory Decline

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01723917
Acronym
phytoSERM
Enrollment
71
Registered
2012-11-08
Start date
2012-07-31
Completion date
2015-01-31
Last updated
2019-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hot Flashes, Memory Loss

Brief summary

The purpose of this study is to evaluate the safety and efficacy of a soy based dietary supplement (phytoSERM) for hot flashes and age associated memory loss.

Interventions

DIETARY_SUPPLEMENTPhytoSERM tablet
DIETARY_SUPPLEMENTplacebo

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of Southern California
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* post-menopausal women * ages 45 - 60 (inclusive) * must have a vasomotor symptom (e.g., hot flash) and a memory complaint

Exclusion criteria

* history of clinically significant stroke * current evidence or history in past 2 years of epilepsy, seizure, focal brain lesion, head injury with loss of consciousness or any major psychiatric disorder including psychosis, major depression, bipolar disorder, alcohol or substance abuse * Known allergy to soy derived products; hypersensitivity to estrogens or progestins

Design outcomes

Primary

MeasureTime frameDescription
safety and tolerability12 weeksas measured by assessment of AEs, co-morbid events, laboratory measures, symptoms and cognitive performance
efficacy12 weekschange from baseline in neuropsychological (cognitive, functional) test results

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026